Cancer

At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.

Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.

Find out more about:

Bill Walsh Translational Cancer Research Laboratory

Bowel Cancer and Biomarker Research Lab

Breast Cancer Research

Cancer Genetics Laboratory

Kolling Institute Tumour Bank

Events, News and Seminars

New approach revolutionising ovarian cancer research

New approach revolutionising ovarian cancer research

With ovarian cancer continuing to have a devastating outcome for many women, new research at the Kol..... Read more

Category: New Treatment, Research Excellence

Recognition of our impact on the world stage

Recognition of our impact on the world stage

Kolling Institute Governance Committee Chair Michael Nugent said it is encouraging to see more than ..... Read more

Category: Research Excellence

Philanthropic funds creating travel opportunities

Philanthropic funds creating travel opportunities

A collection of emerging research leaders will have the chance to broaden their research experience ..... Read more

Category: Awards, Research Excellence